INS and fatty liver disease: Acetate and propionate not only impact glucose production in the liver, potentially improving glucose homeostasis and insulin sensitivity, but also regulate lipid metabolism in the liver by reducing fatty acid and cholesterol synthesis, thus mitigating hepatic steatosis [68].